Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05166109 A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) |
Vamorolone | Myopathies | Phase 2 | COMPLETED | En attente / non publié | Catalyst Pharmaceuticals, Inc. | United States, Italy · Azienda Ospedale Università Pa… | 2022-07-07 → 2025-08-18 | Ouvrir |
| NCT06817382 ASCEND — A Study to Investigate the Safety and Biodistribution of a Sin… |
INS1201 | Myopathies | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Insmed Gene Therapy LLC | United States · Rare Disease Research (USA004), Atlan… | 2025-07-22 → 2028-03-31 | Ouvrir |
| NCT03458832 ReSolve — Clinical Trial Readiness to Solve Barriers to Drug Developmen… |
Electrical Impedance Myography | Myopathies | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Kansas Medical Cent… | United States, France, Germany, Italy, Netherlands, U… | 2018-03-05 → 2027-12 | Ouvrir |
| NCT06754098 Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (… |
doxecitine and doxribtimine | Myopathies | Phase 2 | RECRUITING | En attente / non publié | Cristina Domínguez González | Spain · Hospital Universitario 12 de Octubre, Madrid,… | 2025-01-01 → 2027-12-31 | Ouvrir |
| NCT04253457 The SToICAL Study - The Soft Tissue Injection of Corticosteroid And Loc… |
1ml of triamcinolone (40mg/1ml) | Myopathies | Phase 3 | TERMINATED | En attente / non publié | University Hospital Plymouth NHS … | United Kingdom · University Hospitals Plymouth NHS Tr… | 2020-02-26 → 2025-11-21 | Ouvrir |
| NCT07825792 Light Bulb Stimuli to Reduce Chronic Pain |
S-Cone Stimulating Chromatic Light | Myopathies | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of North Carolina, Cha… | United States · University of North Carolina at Chape… | 2026-09-21 → 2028-01-01 | Ouvrir |
| NCT07827677 The Effect of Different rTMS Interventions on Acute Experimental Muscul… |
Repetitive transcranial magnetic … | Myopathies | Non applicable | RECRUITING | En attente / non publié | The Hong Kong Polytechnic Univers… | Hong Kong · The Hong Kong Polytechnic University, Hon… | 2026-08-31 → 2027-08-31 | Ouvrir |
| NCT06472622 Functional Neuroimaging to Detect the Neural Signatures of the Unpleasa… |
Thermal Pain Stimulation | Myopathies | Phase 1 | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2025-04-09 → 2034-06-30 | Ouvrir |
| NCT07339540 the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recur… |
V001-BCMA | Myopathies | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital, Affiliated to Tongji Medical… | 2025-11-04 → 2028-10-30 | Ouvrir |
| NCT06066580 MESA — Open-Label Extension of EDG-5506 in Participants With Becker Mus… |
Sevasemten | Myopathies | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | Edgewise Therapeutics, Inc. | United States, Australia, Belgium, Denmark, France, G… | 2023-11-02 → 2031-02 | Ouvrir |
| NCT05201469 VIBRANT: VIB4920 for Active Lupus Nephritis |
VIB4920 | Lupus | Phase 2 | RECRUITING | En attente / non publié | National Institute of Allergy and… | United States · Columbia University Medical Center: D… | 2022-12-15 → 2028-12 | Ouvrir |
| NCT07823478 HEALTH Home Urinalysis Testing |
Home Urine Testing | Lupus | Non applicable | RECRUITING | En attente / non publié | NYU Langone Health | United States · NYU Langone Health, New York, United … | 2026-09-08 → 2028-09-30 | Ouvrir |
| NCT07823556 The Role of Transforming Growth Factor- Beta (TGF- β) Expression in Ren… |
renal biopsy | Lupus | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Ain Shams University | Egypt · Ain Shams University, Cairo, Egypt | 2026-05-31 → 2027-09-30 | Ouvrir |
| NCT06916806 TITAN — A Study to Investigate Safety, Tolerability, Pharmacokinetics, … |
AZD5492 | Lupus | Phase 1 | RECRUITING | En attente / non publié | AstraZeneca | United States, Canada, China, France, Germany, Hong K… | 2025-05-01 → 2027-09-15 | Ouvrir |
| NCT05672576 OPUS-2 — A Research Study to Evaluate the Efficacy and Safety of Ceneri… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Chile, Czechia, Georgia, Germany, Indi… | 2023-06-26 → 2027-06-30 | Ouvrir |
| NCT05648500 OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicin… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Argentina, Brazil, Bulgaria, Colombia,… | 2022-12-13 → 2027-09-30 | Ouvrir |
| NCT07328581 A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythema… |
ICG318, BCMA-CD19-IL-15/IL-15 sus… | Lupus | Phase 2 | RECRUITING | En attente / non publié | iCell Gene Therapeutics | United States · Fox Chase Cancer Center- Temple BMT, … | 2026-09 → 2028-12 | Ouvrir |
| NCT06987565 TvSSLE — Transcutaneous Vagus Nerve Stimulation in SLE |
Active vagus nerve stimulation | Lupus | Phase 2 | RECRUITING | En attente / non publié | Northwell Health | United States · Feinstein Institutes for Medical Rese… | 2025-07-25 → 2027-09 | Ouvrir |
| NCT07447986 To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic L… |
SG301 SC Injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hangzhou Sumgen Biotech Co., Ltd. | China · Changzhou Second People's Hospital, Changzhou… | 2026-03-26 → 2027-12-31 | Ouvrir |
| NCT06673043 SLE-ARTEMIS — Anifrolumab Real-world Treatment Outcomes in Systemic Lup… |
Anifrolumab | Lupus | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | Poland · Research Site, Bydgoszcz, Poland | Research … | 2025-02-28 → 2028-06-30 | Ouvrir |
| NCT05440422 The Role of Anifrolumab in Improving Markers of Vascular Risk in Patien… |
Anifrolumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | AstraZeneca | United States · National Institutes of Health Clinica… | 2023-12-07 → 2027-08-02 | Ouvrir |
| NCT04902807 ATRACTion — Conception of a Diagnosis, Prognosis and Therapeutic Decisi… |
Collection of samples | Lupus | À vérifier | COMPLETED | En attente / non publié | Institut National de la Santé Et … | France · Hopital Necker Enfants Malades, Paris, France | 2021-09-07 → 2025-10-21 | Ouvrir |
| NCT07748156 SNC116 Therapy for Refractory Systemic Lupus Erythematosus |
SNC116 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | The Affiliated Nanjing Drum Tower… | China · The Affiliated Nanjing Drum Tower Hospital of… | 2026-10 → 2030-01 | Ouvrir |
| NCT01423006 Pilot Study on Focal Prostate Radio-Frequency Ablation |
Radio-Frequency Ablation (RFA) EN… | Cancer | Non applicable | COMPLETED | En attente / non publié | H. Lee Moffitt Cancer Center and … | United States · H. Lee Moffitt Cancer Center and Rese… | 2011-08 → 2013-03 | Ouvrir |
| NCT05350059 The HIFUB Study (HIFU in Breast Cancer) |
High Intensity Focused Ultrasound… | Cancer | Non applicable | UNKNOWN | En attente / non publié | University of Oxford | Non communiqué | 2022-05-01 → 2022-11-01 | Ouvrir |